|
Volumn 382, Issue 8, 2020, Pages 692-694
|
A novel coronavirus emerging in China - Key questions for impact assessment
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHINA;
CORONAVIRINAE;
CORONAVIRUS DISEASE 2019;
CORONAVIRUS INFECTION;
DISEASE SEVERITY;
DISEASE TRANSMISSION;
HEALTH CARE;
HEALTH CARE FACILITY;
HEALTH CENTER;
HUMAN;
INFLUENZA A VIRUS;
INFLUENZA A VIRUS (H1N1);
JAPAN;
MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS;
NEPAL;
NONHUMAN;
PANDEMIC;
PATHOGENICITY;
PATIENT MONITORING;
PRIORITY JOURNAL;
PUBLIC HEALTH;
REVIEW;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
SINGAPORE;
SOUTH KOREA;
TAIWAN;
THAILAND;
UNITED STATES;
VIET NAM;
BETACORONAVIRUS;
COMMUNICABLE DISEASE CONTROL;
DISEASE NOTIFICATION;
EPIDEMIC;
HEALTH SURVEY;
MORTALITY;
VIROLOGY;
VIRUS PNEUMONIA;
COVID-19;
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2;
BETACORONAVIRUS;
CHINA;
COMMUNICABLE DISEASE CONTROL;
CORONAVIRUS INFECTIONS;
DISEASE NOTIFICATION;
DISEASE OUTBREAKS;
HUMANS;
MORTALITY;
PNEUMONIA, VIRAL;
POPULATION SURVEILLANCE;
|
EID: 85078933824
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp2000929 Document Type: Review |
Times cited : (1054)
|
References (5)
|